Mylan To Launch First Generic To EpiPen At Above 50% Discount To Brand Product

(RTTNews) - Mylan N.V. (MYL) announced Monday that its U.S. subsidiary will launch the first generic to EpiPen Auto-Injector (epinephrine injection, USP) at a list price of $300 per generic EpiPen two-pack carton. The price represents a discount of more than 50% to the Mylan list price, or wholesale acquisition cost, of the branded medicine.

In pre-market activity on Nasdaq, shares were gaining 2.16 percent to trade at $43.96.

EpiPen and EpiPen Jr Auto-Injectors are used for the emergency treatment of life-threatening allergic reactions.

The company said the authorized generic will be identical to the branded product, including device functionality and drug formulation. Mylan expects to launch the product in several weeks, pending completion of labeling revisions.

Upon launch, the product will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths. Mylan also intends to continue to market and distribute branded EpiPen.

The company further said that both the augmented patient assistance program and the $300 savings card announced last week will remain in place for the brand product. The $300 My EpiPen Savings Card acts as cash at the pharmacy and is available at epipen.com/savings.

Mylan also will continue its EpiPen4Schools program. In addition, Mylan intends to initiate a direct ship program in conjunction with the launch of the generic at the $300 generic list price.